Abstract
A case–control study was conducted to determine the association between plasma organochlorine levels and prostate cancer risk. Male clinic patients scheduled for prostate core biopsy or seeing their urologist for other conditions from 1997 through 1999 in Kingston, Ontario were eligible, excluding those with an earlier cancer. Age frequency matched controls (n=329) were compared with 79 incident prostate cancer cases. Before knowledge of diagnosis, the patients completed a questionnaire and donated 15 ml of blood for the measurement of 14 PCBs, and 13 organochlorine pesticides by gas chromatography. At least 70% of patients had detectable levels of nine PCB congeners and seven pesticides, and these chemicals were included in the risk analysis adjusted for total lipids. Geometric means for these PCB congeners, total PCBs, and p,p'-DDE are slightly lower for cases than controls, whereas the levels of p,p'-DDT and other pesticides are virtually equal. Adjusting for age and other confounders in multivariable logistic regression, odds ratios (ORs) are consistently below 1.0 for PCB congeners and total PCBs. For pesticides, most ORs are very close to the null. This study suggests that long-term low-level exposure to organochlorine pesticides and PCBs in the general population does not contribute to increased prostate cancer risk.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aronson K.J., Miller A.B., Woolcott C.G., Sterns E.E., McCReady D.R., Lickley L.A., Fish E.B., Hiraki G.Y., Holloway C., Ross T., Hanna W.M., SenGupta S.K., and Weber J.P. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2000: 9: 55–63.
Band P.R., Le N.D., Fang R., Threlfall W.J., and Gallagher R.P. Identification of occupational cancer risks in British Columbia: Part II: A population-based case-control study of 1516 prostatic cancer cases. J Occup Environ Med 1999: 41 (4): 233–247.
Baris D., Kwak L.W., Rothman N., Wilson W., Manns A., Tarone R.E., and Hartge P. Blood levels of organochlorines before and after chemotherapy among non-Hodgkin's lymphoma patients. Cancer Epidemiol Biomarkers Prevent 2000: 9: 193–197.
Bostwick D.G., Burke H.B., Djakiew D, Euling S, Ho S.M, Landolph J, Morrison H, Sonawane B, Shifflett T, Waters D.J and Timm S . Human prostate cancer risk factors. Cancer 2004: 101 (10 Suppl): 2371–2490
Carter B.S., Bova G.S., Beaty T.H., Steinberg G.D., Childs B., Isaacs W., and Walsh P.C. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993: 150: 797–802.
Cerhan J.R., Parker A.S., Putnam S.D., Chiu B.C.-H., Lynch C.F., Cohen M.B., Torner J.C., and Cantor K.P. Family history and prostate cancer risk in a population based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev 1999: 8: 53–60.
Charlier C.J., and Plomteux G.J. Determination of organochlorine pesticide residues in the blood of healthy individuals. Clin Chem Lab Med 2002: 40 (4): 361–364.
Chen C. Risk of prostate cancer in relation to polymorphisms of metabolic genes. Epidemiol Rev 2001: 23: 30–35.
Clinton S.K., and Giovannucci E. Diet, nutrition, and prostate cancer. Ann Rev Nutr 1998: 18: 413–440.
Cohn B.A., Wolff M.S., Cirillo P.M., and Sholtz R.I. DDT and breast cancer in young women: new data on the significance of age at exposure. Environ Health Perspect 2007: 115 (10): 1406–1414.
Davis D.L., Bradlow H.L., Wolff M., Woodruff T., Hoel D.G., and Anton-Culver H. Medical hypotheses: xenoestrogens as preventable causes of breast cancer. Environ Health Prospect 1993: 101: 372–377.
DeMarzo A.M., Coffey D.S., and Nelson W.G. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. Urology 1999: 53 (suppl 3a): 29–40.
Demers A., Ayotte P., Brisson J., Dodin S., Robert J., and Dewailly E. Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: a congener-specific analysis. Am J Epidemiol 2002: 155 (7): 629–635.
Dennis L.K., Lynch C.F., and Torner J.C. Epidemiologic association between prostatitis and prostate cancer. Urology 2002: 60 (1): 78–83.
Fleming L.E., Bean J.A., Rudolph M., and Hamilton K. Cancer incidence in a cohort of licensed pesticide applicators in Florida. J Occup Environ Med 1999: 41 (4): 279–288.
Forastiere F., Quercia A., Miceli M., Settimi L., Terenzoni B., Rapiti E., Faustini A., Borgia P., Cavariani F., and Perucci C.A. Cancer among farmers in central Italy. Scand J Work Environ Health 1993: 19: 382–389.
Gann P.H., Hennekens C.H., Ma J., Longcope C., and Stampfer M.J. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 1996: 88: 1118–1126.
Golden R.J., Noller K.L., Titus-Ernstoff L., Kaufman R.H., Mittendorf R., Stillman R., and Reese E.A. Environmental endocrine modulators and human health: an assessment of the biological evidence. Crit Rev Toxicol 1998: 28 (2): 109–227.
Guess H.A. Benign prostatic hyperplasia and prostate cancer. Epidemiol Rev 2001: 23 (1): 152–158.
Haldane J.B.S. The estimation and significance of the logarithm of a ratio of frequencies. Ann Human Genet 1955: 20: 309–311.
Hayes R.B., Ziegler R.G., Gridley G., Swanson C., Greenberg R.S., Swanson G.M., Schoenberg J.B., Silverman D.T., Brown L.M., Pottern L.M., Liff J., Schwartz A.G., Fraumeni J.F., and Hoover R.N. Dietary factors and risks for prostate cancer among Blacks and Whites in the United States. Cancer Epidemiol Biomarkers Prev 1999: 8: 25–34.
Hsieh C-C., Signorello L.B., Lipworth L., Lagiou P., Mantzoros C.S., and Trichopoulos D. Predictors of sex hormone levels among the elderly: a study in Greece. J Clin Epidemiol 1998: 51: 837–841.
Jana N.R., Sarkar S., Ishizuka M., Yonemoto J., Tohyama C., and Sone H. Cross-talk between 2,3,7,8-tetrachlorodibenzo-p-dioxin and testosterone signal transduction pathways in LNCaP prostate cancer cells. Biochem Biophys Res Commun 1999: 256 (3): 462–468.
Keller-Byrne J.E., Khuder S.A., and Schaub E.A. Meta-analyses of prostate cancer and farming. Am J Ind Med 1997: 31 (5): 580–586.
Kolonel L.N. Nutrition and prostate cancer. Cancer Causes and Control 1996: 7: 83–94.
Kristal A.R., and Cohen J.H. Invited commentary: tomatoes, lycopene, and prostate cancer. How strong is the evidence? Am J Epidemiol 2000: 2: 124–127.
Lesko S.M., Rosenberg L., and Shapiro S. Family history and prostate cancer risk. Am J Epidemiol 1996: 144: 1041–1047.
McFarland V.A., and Clarke J.U. Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis. Environ Health Perspect 1989: 81: 225–239.
Meyer T.E., Coker A.L., Sanderson M., and Symanski E. A case-control study of farming and prostate cancer in African-American and Caucasian men. J Occup Environ Med 2007: 64: 155–160.
Miller W.R., and Sharpe R.M. Environmental oestrogens and human reproductive cancer? Endocr Relat Cancer 1998: 5: 69–96, 1998.
Morris J.J., and Seifter E. The role of aromatic hydrocarbons in the genesis of breast cancer. Med Hypotheses 1992: 38: 177–184.
Parent M.E., and Siemiatycki J. Occupation and prostate cancer. Epidemiol Rev 2001: 23 (1): 138–143.
Phillips D.L., Pirkle J.L., Burse V.W., Bernert Jr J.T., Henderson L.O., and Needham L.L. Chlorinated hydrocarbon levels in human serum: Effects of fasting and feeding. Arch Environ Contam Toxicol 1989: 18: 495–500.
Richardson H., Aronson K.J., James A., MacGregor E., and Bryant H. Factors related to the use of prostate cancer screening in the Alberta Tomorrow Project. Open Med 2007: 1 (1): e3–e12.
Ritchie J.M., Vial S.L., Fuortes L.J., Guo H., Reedy V.E., and Smith E.M. Organochlorines and risk of prostate cancer. J Occup Environ Med 2003: 45 (7): 692–702.
Rodriguez C., Calle E.E., Miracle-McMahill H.L., Tatham L.M., Wingo P.A., Thun M.J., and Heath Jr C.W. Family history and risk of fatal prostate cancer. Epidemiology 1997: 8: 653–657.
Rogan W.J., and Chen A. Health risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT). Lancet 2005: 366: 763–773.
Rothman K.J., and Greenland S. Introduction to Categorical Statistics. In: Rothman K.J., and Greenland S. (Eds.). Modern Epidemiology. Lippincott-Raven, Philadelphia, 1998, pp 231–252.
Sala M., Sunyer J., Otero R., Santiago-Silva M., Camps C., and Grimalt J. Organochlorines in the serum of inhabitants living near an electrochemical factory. Occup Environ Med 1999: 56 (3): 152–158.
Schaufler K., Haslmayer P., Jager W., Pec M., and Thalhammer T. The environmental toxin 2,3,7,8-tetrachlorodibenzo-p-dioxin induces cytochrome P450 activity in high passage PC 3 and DU 145 human prostate cancer cell lines. Inter J Mol Med 2002: 9 (4): 411–416.
Schrader T.J., and Cooke G.M. Examination of selected food additives and organochlorine food contaminants for androgenic activity in vitro. Toxicol Sci 2000: 53 (2): 278–288.
Schreinemachers D.M., Creason J.P., and Garry V.F. Cancer mortality in agricultural regions of Minnesota. Environ Health Perspect 1999: 107: 205–211.
Settimi L., Comba P., Bosia S., Ciapini C., Desideri E., Fedi A., Perazzo P.L., and Axelson O. Cancer risk among male farmers: a multi-site case-control study. Inter J Occup Med Environ Health 2001: 14: 339–348.
Settimi L., Masina A., Andrion A., and Axelson O. Prostate cancer and exposure to pesticides in agricultural setting. Inter J Cancer 2003: 104: 458–461.
Sharma-Wagner S., Chokkalingam A.P., Malker H.S., Stone B.J., McLaughlin J.K., and Hsing A.W. Occupation and prostate cancer risk in Sweden. J Occupat Environ Med 2000: 42 (5): 517–525.
Sharpe C.R., Siemiatycki J., and Parent M.E. Activities and exposures during leisure and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2001: 10: 855–860.
Shields P.G. Understanding population and individual risk assessment: the case of polychlorinated biphenyls. Cancer Epidemiol Biomarkers Prev 2006: 15 (5): 830–839.
Smith A.G. Chlorinated hydrocarbon insecticides. In: Hayes W.J., and Laws E.R. (Eds.). Handbook of Pesticide Toxicology. Academic Press Inc., San Diego/New York, 1991, 731–915.
Sonnenschein C., and Soto A.M. An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol 1998: 65: 143–150.
Stanford J.L., and Ostrander E.A. Familial prostate cancer. Epidemiol Rev 2003: 23: 19–23.
Tessier D.M., and Matsumura F. Increased ErbB-2 tyrosine kinase activity, MAPK phosphorylation, and cell proliferation in the prostate cancer cell line LNCaP following treatment by select pesticides. Toxicol Sci 2001: 60 (1): 38–43.
Turusov V., Rakitsky V., and Tomatis L. Dichlorodiphenyltrichloroethane (DDT): ubiquity, persistence, and risks. Environ Health Perspect 2002: 110 (2): 125–128.
Van Der Gulden J.W., and Vogelzang P.F. Farmers at risk for prostate cancer. Br J Urol 1996: 77 (1): 6–14.
Whittemore A.S., Kolonel L.N., Wu A.H., John E.M., Gallagher R.P., Howe G.R., Burch J.D., Hankin J., Dreon D.M., West D.W., The C.-Z., and Paffenbarger Jr R.S. Prostate cancer in relation to diet, physical activity and body size in blacks, whites, and Asians in the U.S. and Canada. J Natl Cancer Inst 1995a: 87: 652–661.
Whittemore A.S., Wu A.H., Kolonel L.N., John E.M., Gallagher R.P., Howe G.R., West D.W., The C.Z., and Stamey T. Family history and prostate cancer risk in black, white and Asian men in the United States and Canada. Am J Epidemiol 1995b: 141: 732–740.
Wilkinson P., Thakrar B., Shaddick G., Stevenson S., Pattenden S., Landon M., Grundy C., and Elliott P. Cancer incidence and mortality around the Pan Britannica Industries pesticide factory, Waltham Abbey. Occupat Environ Med 1997: 54 (2): 101–107.
Wolff M.S., Camann D., Gammon M., and Stellman S.D. Proposed PCB congener groupings for epidemiological studies. Environ Health Perspect 1997: 105: 13–14.
Wolff M.S., Zeleniuch-Jacquotte A., Dubin N., and Toniolo P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev 2000: 9 (3): 271–277.
World Health Organization, International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: DDT and Associated Compounds. IARC, Lyon, France, 1997.
World Health Organization, International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Polychlorinated Biphenyls. IARC, Lyon, France, 1998.
Zafar M.B., and Terris M.K. Prostate cancer detection in veterans with a history of Agent Orange exposure. J Urol 2001: 166 (1): 100–103.
Acknowledgements
We thank the following for their invaluable contributions: study participants, Linda Levesque, Catherine Elliott, Jean-Philippe Weber, and Jane Rixten. This study was funded by the Canadian Institutes of Health Research; Astra-Zeneca; by the Investigator Award to KJA from the Canadian Institutes of Health Research; and by the Career Scientist Award to KJA from the Ontario Ministry of Health and Long-Term Care.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Aronson, K., Wilson, J., Hamel, M. et al. Plasma organochlorine levels and prostate cancer risk. J Expo Sci Environ Epidemiol 20, 434–445 (2010). https://doi.org/10.1038/jes.2009.33
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jes.2009.33
Keywords
This article is cited by
-
Toxicokinetics of chiral polychlorinated biphenyls across different species—a review
Environmental Science and Pollution Research (2016)
-
Organochlorine pesticides and prostate cancer, Is there an association? A meta-analysis of epidemiological evidence
Cancer Causes & Control (2015)
-
Body concentrations of persistent organic pollutants and prostate cancer: a meta-analysis
Environmental Science and Pollution Research (2015)
-
High-performance metabolic profiling with dual chromatography-Fourier-transform mass spectrometry (DC-FTMS) for study of the exposome
Metabolomics (2013)